Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 728741, 12 pages
http://dx.doi.org/10.1155/2015/728741
Research Article

An Altered Pattern of Myocardial Histopathological and Molecular Changes Underlies the Different Characteristics of Type-1 and Type-2 Diabetic Cardiac Dysfunction

1Department of Cardiac Surgery, University of Heidelberg, INF 326 OG 2, 69120 Heidelberg, Germany
2Heart and Vascular Center, Semmelweis University, Városmajor u. 68, 1122 Budapest, Hungary

Received 4 August 2014; Revised 18 October 2014; Accepted 20 October 2014

Academic Editor: Raffaele Marfella

Copyright © 2015 Tamás Radovits et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Boudina and E. D. Abel, “Diabetic cardiomyopathy revisited,” Circulation, vol. 115, no. 25, pp. 3213–3223, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. D. An and B. Rodrigues, “Role of changes in cardiac metabolism in development of diabetic cardiomyopathy,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 291, no. 4, pp. H1489–H1506, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. D. A. Rees and J. C. Alcolado, “Animal models of diabetes mellitus,” Diabetic Medicine, vol. 22, no. 4, pp. 359–370, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. R. S. Guleria, A. B. Singh, I. T. Nizamutdinova et al., “Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats,” Journal of Molecular and Cellular Cardiology, vol. 57, no. 1, pp. 106–118, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. L. S. Mansor, E. R. Gonzalez, M. A. Cole et al., “Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin,” Cardiovascular Diabetology, vol. 12, no. 1, article 136, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. T. Radovits, S. Korkmaz, S. Loganathan et al., “Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 297, no. 1, pp. H125–H133, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. M. Aragno, R. Mastrocola, G. Alloatti et al., “Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats,” Endocrinology, vol. 149, no. 1, pp. 380–388, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. L. Cai and Y. J. Kang, “Cell death and diabetic cardiomyopathy,” Cardiovascular Toxicology, vol. 3, no. 3, pp. 219–228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Huynh, B. C. Bernardo, J. R. McMullen, and R. H. Ritchie, “Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways,” Pharmacology and Therapeutics, vol. 142, no. 3, pp. 375–415, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. T. Radovits, T. Bömicke, G. Kökény et al., “The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus,” British Journal of Pharmacology, vol. 156, no. 6, pp. 909–919, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. P. Pacher, T. Nagayama, P. Mukhopadhyay, S. Bátkai, and D. A. Kass, “Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats,” Nature Protocols, vol. 3, no. 9, pp. 1422–1434, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. L. Liaudet, F. G. Soriano, É. Szabó et al., “Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 18, pp. 10203–10208, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. J. Kajstura, F. Fiordaliso, A. M. Andreoli et al., “IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress,” Diabetes, vol. 50, no. 6, pp. 1414–1424, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Song, K. H. Kuo, R. Yao, S. R. Hutchings, and C. C. Y. Pang, “Inducible nitric oxide synthase depresses cardiac contractile function in Zucker diabetic fatty rats,” European Journal of Pharmacology, vol. 579, no. 1–3, pp. 253–259, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. F. Fiordaliso, B. Li, R. Latini et al., “Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II- dependent,” Laboratory Investigation, vol. 80, no. 4, pp. 513–527, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Frustaci, J. Kajstura, C. Chimenti et al., “Myocardial cell death in human diabetes,” Circulation Research, vol. 87, no. 12, pp. 1123–1132, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. W. J. Paulus and C. Tschöpe, “A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation,” Journal of the American College of Cardiology, vol. 62, no. 4, pp. 263–271, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. L. Van Heerebeek, N. Hamdani, M. L. Handoko et al., “Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension,” Circulation, vol. 117, no. 1, pp. 43–51, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. D. T. Loo, “In situ detection of apoptosis by the TUNEL assay: an overview of techniques,” Methods in Molecular Biology, vol. 682, pp. 3–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Ramírez, M. Klett-Mingo, S. Ares-Carrasco et al., “Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes,” Cardiovascular Diabetology, vol. 12, no. 1, article 172, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. W. Min, Z. W. Bin, Z. B. Quan, Z. J. Hui, and F. G. Sheng, “The signal transduction pathway of PKC/NF-κB/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats,” Cardiovascular Diabetology, vol. 8, article 8, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. W. Nadruz Jr., M. A. F. Corat, T. M. Marin, G. A. Guimarães Pereira, and K. G. Franchini, “Focal adhesion kinase mediates MEF2 and c-Jun activation by stretch: role in the activation of the cardiac hypertrophic genetic program,” Cardiovascular Research, vol. 68, no. 1, pp. 87–97, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. E. J. Cox and S. A. Marsh, “A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes,” PLoS ONE, vol. 9, no. 3, Article ID e92903, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. S. Fredersdorf, C. Thumann, C. Ulucan et al., “Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats,” Cardiovascular Pathology, vol. 13, no. 1, pp. 11–19, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. Z. Xia, K. H. Kuo, P. R. Nagareddy et al., “N-acetylcysteine attenuates PKCβ2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats,” Cardiovascular Research, vol. 73, no. 4, pp. 770–782, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. Taye, M. M. Abouzied, and O. M. M. Mohafez, “Tempol ameliorates cardiac fibrosis in streptozotocin-induced diabetic rats: role of oxidative stress in diabetic cardiomyopathy,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 386, no. 12, pp. 1071–1080, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. S. A. Marsh, P. C. Powell, A. Agarwal, L. J. Dell'Italia, and J. C. Chatham, “Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: role of hydronephrosis,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 1, pp. H292–H298, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. A. Daniels, D. Linz, M. Van Bilsen et al., “Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats,” European Journal of Heart Failure, vol. 14, no. 2, pp. 193–201, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. H. Farhangkhoee, Z. A. Khan, H. Kaur, X. Xin, S. Chen, and S. Chakrabarti, “Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets,” Pharmacology and Therapeutics, vol. 111, no. 2, pp. 384–399, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. B. Widyantoro, N. Emoto, K. Nakayama et al., “Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition,” Circulation, vol. 121, no. 22, pp. 2407–2418, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. A. González, S. Ravassa, J. Beaumont, B. López, and J. Díez, “New targets to treat the structural remodeling of the myocardium,” Journal of the American College of Cardiology, vol. 58, no. 18, pp. 1833–1843, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus